Characterization of a neurovirulent aciclovir-resistant variant of herpes simplex virus

Journal of General Virology

Volumn 84, Issue 6, 2003, Pages 1403-1410

  Grey, Finn ^a   Sowa, Mike ^b   Collins, Peter ^b   Fenton, Rob J ^b   Harris, Wendy ^b   Snowden, Wendy ^b   Efstathiou, Stacey ^a   Darby, Graham ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; GUANINE; THYMIDINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GANGLION; GENE INSERTION; HERPES; HERPES SIMPLEX VIRUS 1; HUMAN; LATENT VIRUS INFECTION; MOUSE; MUTATION RATE; NERVOUS SYSTEM; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; VIRAL GENETICS; VIRUS ISOLATION; VIRUS MUTATION; VIRUS REACTIVATION; VIRUS VIRULENCE;

ACYCLOVIR; AMINO ACID SEQUENCE; ANIMALS; ANTIVIRAL AGENTS; BASE SEQUENCE; CELL LINE; CERCOPITHECUS AETHIOPS; CRICETINAE; DNA, VIRAL; DRUG RESISTANCE, VIRAL; FRAMESHIFT MUTATION; GANGLIA, SENSORY; GENOTYPE; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; MUTATION; OPEN READING FRAMES; PHENOTYPE; PROTEIN BIOSYNTHESIS; THYMIDINE KINASE; VARIATION (GENETICS); VERO CELLS; VIRULENCE;

ANIMALIA; DNA VIRUSES; HUMAN HERPESVIRUS 1; INSERTION SEQUENCES; SIMPLEXVIRUS;

EID: 0037872697     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.18881-0     Document Type: Article

References (29)

1. Biron, K. K., Fyfe, J. A., Stanat, S. C., Leslie, L. K., Sorrell, J. B., Lambe, C. U. & Coen, D. M. (1986). A human cytomegalovirus mutant resistant to the nucleoside analog 9-([2-hydroxy-1-(hydroxymethyl)-ethoxy]methyl) guanine (BW B759U) induces reduced levels of BW B759U triphosphate. Proc Natl Acad Sci U S A 83, 8769-8773.
2. Brown, D. G., Visse, R., Sandhu, G., Davies, A., Rizkallah, P. J., Melitz, C., Summers, W. C. & Sanderson, M. R. (1995). Crystal structures of the thymidine kinase from herpes simplex virus type-1 in complex with deoxythymidine and ganciclovir. Nat Struct Biol 2, 876-881.
3. Christophers, J., Clayton, J., Craske, J., Ward, R., Collins, P., Trowbridge, M. & Darby, G. (1998). Survey of resistance of herpes simplex virus to acyclovir in northwest England. Antimicrob Agents Chemother 42, 868-872.
4. Coen, D. M. & Schaffer, P. A. (1980). Two distinct loci confer resistance to acycloguanosine in herpes simplex virus type 1. Proc Natl Acad Sci U S A 77, 2265-2269.
5. Coen, D. M., Irmiere, A. F., Jacobson, J. G. & Kerns, K. M. (1989). Low levels of herpes simplex virus thymidine-thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model. Virology 168, 221-231.
6. Collins, P. & Darby, G. (1991). Laboratory studies of herpes simplex virus strains resistant to acyclovir. Rev Med Virol 1, 19-28.
7. Efstathiou, S., Kemp, S., Darby, G. & Minson, A. C. (1989). The role of herpes simplex virus type 1 thymidine kinase in pathogenesis. J Gen Virol 70, 869-879.
8. Erlich, K. S., Mills, J., Chatis, P., Mertz, G. J., Busch, D. F., Follansbee, S. E., Grant, R. M. & Crumpacker, C. S. (1989). Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome. N Engl J Med 320, 293-296.
9. Field, H. J. & Wildy, P. (1978). The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in mice. J Hyg 81, 267-277.
10. Field, H. J. & Darby, G. (1980). Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivo. Antimicrob Agents Chemother 17, 209-216.
11. Griffiths, A. & Coen, D. M. (2003). High frequency phenotypic reversion and pathogenicity of an acyclovir-resistant herpes simplex virus mutant. J Virol 77, 2282-2286.
12. Harris, W., Collins, P., Fenton, R. J., Snowden, W., Sowa, M. & Darby, G. (2003). Phenotypic and genotypic characterization of clinical isolates of herpes simplex virus resistant to acyclovir. J Gen Virol 84, 1393-1401.
13. Hill, T. J., Field, H. J. & Blyth, W. A. (1975). Acute and recurrent infection with herpes simplex virus in the mouse: a model for studying latency and recurrent disease. J Gen Virol 28, 341-353.
14. Hill, E. L., Hunter, G. A. & Ellis, M. N. (1991). In vitro and in vivo characterization of herpes simplex virus clinical isolates recovered from patients infected with human immunodeficiency virus. Antimicrob Agents Chemother 35, 2322-2328.
15. Horsburgh, B. C., Chen, S. H., Hu, A., Mulamba, G. B., Burns, W. H. & Coen, D. M. (1998). Recurrent acyclovir-resistant herpes simplex in an immunocompromised patient: can strain differences compensate for loss of thymidine kinase in pathogenesis? J Infect Dis 178, 618-625.
16. Hwang, C. B., Horsburgh, B., Pelosi, E., Roberts, S., Digard, P. & Coen, D. M. (1994). A net + 1 frameshift permits synthesis of thymidine kinase from a drug-resistant herpes simplex virus mutant. Proc Natl Acad Sci U S A 91, 5461-5465.
17. Jacobson, J. G., Ruffner, K. L., Kosz-Vnenchak, M., Hwang, C. B., Wobbe, K. K., Knipe, D. M. & Coen, D. M. (1993). Herpes simplex virus thymidine kinase and specific stages of latency in murine trigeminal ganglia. J Virol 67, 6903-6908.
18. Kost, R. G., Hill, E. L., Tigges, M. & Straus, S. E. (1993). Brief report: recurrent acyclovir-resistant genital herpes in an immunocompetent patient. N Engl J Med 329, 1777-1782.
19. Littler, E., Stuart, A. D. & Chee, M. S. (1992). Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir. Nature 358, 160-162.
20. Nugier, F., Colin, J. N., Aymard, M. & Langlois, M. (1992). Occurrence and characterization of acyclovir-resistant herpes simplex virus isolates: report on a two-year sensitivity screening survey. J Med Virol 36, 1-12.
21. O'Brian, J. J. & Campoli-Richards, D. M. (1989). Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs 37, 233-309.
22. Sakuma, S., Yamamoto, M., Kumano, Y. & Mori, R. (1988). An acyclovir-resistant strain of herpes simplex virus type 2 which is highly virulent for mice. Arch Virol 101, 169-182.
23. Sasadeusz, J. J., Tufaro, F., Safrin, S., Schubert, K., Hubinette, M. M., Cheung, P. K. & Sacks, S. L. (1997). Homopolymer mutational hot spots mediate herpes simplex virus resistance to acyclovir. J Virol 71, 3872-3878.
24. Sibrack, C. D., Gutman, L. T., Wilfert, C. M., McLaren, C., St Clair, M. H., Keller, P. M. & Barry, D. W. (1982a). Pathogenicity of acyclovir-resistant herpes simplex virus type 1 from an immunodeficient child. J Infect Dis 146, 673-682.
25. Sibrack, C. D., McLaren, C. & Barry, D. W. (1982b). Disease and latency characteristics of clinical herpes virus isolated after acyclovir therapy. Am J Med 73, 372-375.
26. Stow, N. D. & Wilkie, N. M. (1976). An improved technique for obtaining enhanced infectivity with herpes simplex virus type 1 DNA. J Gen Virol 33, 447-458.
27. Tenser, R. B. & Dunstan, M. E. (1979). Herpes simplex virus thymidine kinase expression in infection of the trigeminal ganglion. Virology 99, 417-422.
28. Tenser, R. B., Ressel, S. & Dunstan, M. E. (1981). Herpes simplex virus thymidine kinase expression in trigeminal ganglion infection: correlation of enzyme activity with ganglion virus titer and evidence of in vivo complementation. Virology 112, 328-341.
29. Wade, J. C., Newton, B., McLaren, C., Flournoy, N., Keeney, R. E. & Meyers, J. D. (1982). Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial. Ann Intern Med 96, 265-269.